Home
Conditions
Metastatic Pancreatic Cancer

Clinical trial condition

Metastatic Pancreatic Cancer

Explore clinical trials studying Metastatic Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

134 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Pancreatic Cancer trial results

Recruiting

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

NCT06361888

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China

Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

NCT06483555

Conditions: Basal Cell Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients

NCT05065801

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: CHU Grenoble Grenoble, Auvergne-Rhône-Alpes, France

CHU St Etienne Saint-Etienne, Auvergne-Rhône-Alpes, France

Institut GODINOT Reims, Grand Est, France

CHU St Eloi Montpellier, Herault, France

View Trial Details

Recruiting

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

NCT05380414

Conditions: Advanced Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Centre Léon Bérard Lyon, France

View Trial Details

Recruiting

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

NCT04605913

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

NCT06861088

Conditions: Cardiovascular Diseases, Digestive System Diseases, Digestive System Neoplasms, +18 more
Locations: Ventura Clinical Trials Ventura, California, United States

Clavis Medical, LLC Miami Lakes, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Recruiting

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

NCT04150042

Conditions: Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation, +35 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

NCT06951997

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Recruiting

Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy

NCT05927142

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Erasmus MC Rotterdam, South Holland, Netherlands

View Trial Details

Recruiting

A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

NCT06782555

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +22 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer trial results

Related conditions